These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23452678)

  • 21. ADHD treatment and the risk of substance abuse.
    Sircy RA; Stojanoski A
    Nurse Pract; 2008 Apr; 33(4):33-6. PubMed ID: 18388552
    [No Abstract]   [Full Text] [Related]  

  • 22. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH
    Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADHD: monitoring for and managing stimulant adverse effects.
    Mercer M; Farver D
    S D Med; 2013 Dec; 66(12):511, 513. PubMed ID: 24527549
    [No Abstract]   [Full Text] [Related]  

  • 24. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Methylphenidate induced ST elevation acute myocardial infarction].
    Ruwald MH; Ruwald AC; Tønder N
    Ugeskr Laeger; 2012 Mar; 174(10):647-8. PubMed ID: 22395014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and management of adult attention-deficit/hyperactivity disorder.
    Post RE; Kurlansik SL
    Am Fam Physician; 2012 May; 85(9):890-6. PubMed ID: 22612184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 28. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M; Uekermann J; Wiltfang J; Kis B
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention-deficit hyperactivity disorder: alternatives for psychotherapy?
    Calhoun G; Fees CK; Bolton JA
    Percept Mot Skills; 1994 Aug; 79(1 Pt 2):657-8. PubMed ID: 7808906
    [No Abstract]   [Full Text] [Related]  

  • 30. A rare case of dependence on pemoline.
    Bonnet U; Davids E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylphenidate and dextroamphetamine abuse in substance-abusing adolescents.
    Williams RJ; Goodale LA; Shay-Fiddler MA; Gloster SP; Chang SY
    Am J Addict; 2004; 13(4):381-9. PubMed ID: 15370936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of attention-deficit/hyperactivity disorder.
    Pierce K
    Pediatr Ann; 2011 Nov; 40(11):556-62. PubMed ID: 22066507
    [No Abstract]   [Full Text] [Related]  

  • 34. Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.
    Young S; Sedgwick O
    Expert Rev Neurother; 2015; 15(9):1005-14. PubMed ID: 26289485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulant medications: how to minimize their reinforcing effects?
    Volkow ND
    Am J Psychiatry; 2006 Mar; 163(3):359-61. PubMed ID: 16513852
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of attention deficit hyperactivity disorder in adults.
    Greenfield B; Hechman L
    Expert Rev Neurother; 2005 Jan; 5(1):107-21. PubMed ID: 15853481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents.
    Feldman HM; Reiff MI
    N Engl J Med; 2014 Feb; 370(9):838-46. PubMed ID: 24571756
    [No Abstract]   [Full Text] [Related]  

  • 38. [Central stimulants in adults with AD/HD. Can they be abused?].
    Lie N
    Tidsskr Nor Laegeforen; 1998 Nov; 118(27):4227-9. PubMed ID: 9857807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). Four pertinent issues in treatment.
    Luk ES
    Aust N Z J Psychiatry; 2002 Aug; 36(4):479-81. PubMed ID: 12169143
    [No Abstract]   [Full Text] [Related]  

  • 40. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.